Ryan Halsted
Stock Analyst at RBC Capital
(0.62)
# 4,152
Out of 5,138 analysts
6
Total ratings
50%
Success rate
-15.45%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Outperform | $47 | $42.71 | +10.04% | 1 | Jan 12, 2026 | |
| PRVA Privia Health Group | Reinstates: Outperform | $31 | $23.86 | +29.92% | 1 | Jan 9, 2026 | |
| TBRG TruBridge | Reinstates: Sector Perform | $23 | $21.74 | +5.80% | 1 | Jan 9, 2026 | |
| ENSG The Ensign Group | Downgrades: Underperform | n/a | $183.54 | - | 3 | Apr 28, 2017 |
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $42.71
Upside: +10.04%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $23.86
Upside: +29.92%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $21.74
Upside: +5.80%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $183.54
Upside: -